Related Experiment Videos
Lung transplantation for interstitial lung disease
Brandon S Lu1, Sangeeta M Bhorade
1Division of Pulmonary and Critical Care Medicine, Loyola University Medical Center, 2160 South 1st Avenue, Maywood, IL 60153, USA.
Clinics in Chest Medicine
|November 27, 2004
Summary
Lung transplantation improves survival for end-stage interstitial lung diseases. This review covers current indications, outcomes, and challenges for lung transplants in these patients.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Transplant Medicine
Background:
- Interstitial lung diseases (ILDs) are a group of progressive lung disorders.
- Lung transplantation is a vital treatment for end-stage ILDs.
- Idiopathic pulmonary fibrosis is the primary indication for lung transplantation.
Purpose of the Study:
- To review current indications for lung transplantation in ILD patients.
- To discuss outcomes and challenges associated with lung transplantation for ILDs.
- To explore the role of lung transplantation in specific ILD subtypes.
Main Methods:
- Literature review of studies on lung transplantation for ILDs.
- Analysis of current clinical guidelines and outcomes data.
- Discussion of specific disease considerations in lung transplantation.
Main Results:
- Lung transplantation offers improved survival for select end-stage ILD patients.
- Indications are expanding beyond idiopathic pulmonary fibrosis.
- Outcomes vary depending on the specific ILD and patient factors.
Conclusions:
- Lung transplantation is a critical intervention for end-stage ILDs.
- Careful patient selection and management are essential for successful outcomes.
- Further research is needed to optimize transplant strategies for diverse ILDs.